期刊文献+

肝移植术后新发肺癌1例临床分析附文献复习 被引量:2

De novo lung cancer after liver transplantation:report of one case and literature review
下载PDF
导出
摘要 目的探讨肝移植术后新发肺癌的临床特点、危险因素、预防及治疗。方法回顾性分析2003年10月至2009年12月间接受肝移植术的726例受者中的1例新发肺癌病例的临床资料。结果该院肝移植术后新发肺癌发生率0.14%(1/726)。该例为男性,肝移植时年龄为57岁,从接受肝移植手术至发生肿瘤历时26个月,从确诊新发肺癌至死亡历时10个月,死于肿瘤进展、多器官功能衰竭。结论肝移植术后新发肺癌的发生率较低;确诊时间较晚,疗效不佳;重视肝移植术后随访,早期诊断和早期治疗新发肺癌是提高疗效的关键措施。 Objective To analyze the clinical characteristics,risk factors,prevention and treatments of de novo lung cancer after liver transplantation(LT).Methods The clinical data of one patient with de novo lung cancer out of the 726 patients undergoing LT from October 2003 to December 2009 were analyzed.Results The morbidity of de novo lung cancer after LT in our institution was 0.14%(1/726).The age of the patient(male)with LT history was 57 years old.The tumor was diagnosed 26 months after LT and survived for 10 months.The patient died of tumor progression and multiple organ failure eventually.Conclusion The incidence of de novo lung cancer after LT is low with delayed diagnosis time and bad curative effect as a whole.Carefully analyzing lesion precancerous and high risk factors,early diagnosis,early treatment are the keys to improve the survival time.
出处 《器官移植》 CAS 2010年第5期281-286,共6页 Organ Transplantation
基金 国家重点基础研究发展计划项目(973分课题)(2009CB522404) 国家自然科学基金面上项目(30972914) 十一五科技攻关项目(2008ZX10002-025) 广东省科技计划项目(2009A030200006) 广州省科技计划项目重大专项(2007A032000001) 广州市科技计划项目(200921Z1-E211)
关键词 肝移植 新发恶性肿瘤 肺癌 Liver transplantation De novo malignant tumors Lung cancer
  • 相关文献

参考文献54

  • 1Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single-center study [J]. Transplant Proc, 1993, 25(1 Pt 2) : 1397-1399. 被引量:1
  • 2Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation [ J ] . Hepatogastroenterology, 1997, 44 (16): 1172-1181. 被引量:1
  • 3Jonas S, Rayes N, Neumann U, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin[J]. Cancer, 1997, 80(6): 1141-1150. 被引量:1
  • 4Kelly DM, Emre S, Guy SR, et al. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors[J]. Cancer, 1998, 83(6): 1237-1243. 被引量:1
  • 5Berenguer M, Prieto M, Bustamante M, et al. Incidence of de novo neoplasms after liver transplantation [ J ]. Med Clin (西班牙文), 1998, 111 (13): 481-484. 被引量:1
  • 6Peyregne V, Ducerf C, Adham M, et al. De novo cancer after orthotopic liver transplantation[ J]. Transplant Proc, 1998, 30 (4): 1484-1485. 被引量:1
  • 7Galve ML, Cuervas-Mons V, Figueras J, et al. Incidence and outcome of de novo malignancies after liver transplantation[J]. Transplant Proc, 1999, 31(1-2): 1275-1277. 被引量:1
  • 8Jain A, DiMartini A, Kashyap R, et al. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus [ J ]. Transplantation, 2000, 70 (9) : 1335-1342. 被引量:1
  • 9Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving> or = 5 years after liver transplant [ J ]. Transplantation, 2000, 69 (5): 781-789. 被引量:1
  • 10Jaurrieta E, Casais L, Figueras J, et al. Analysis of 500 liver transplantations at Bellvitge Hospital, Spain [ J ].Ned Clin(西班牙文),2000,115(14):521-529. 被引量:1

二级参考文献62

  • 1王立夫,章永平,江石湖,康微,郑仲承,刘新桓.聚乙二醇修饰重组人白细胞介素-2的体内抗小鼠宫颈癌作用[J].中华肿瘤杂志,1996,18(4):253-255. 被引量:2
  • 2朱志军,李林,张雅敏,郑虹,蒋文涛,张建军,高伟,淮明生,沈中阳.肝移植术后新发恶性肿瘤的诊治[J].中华肿瘤杂志,2007,29(3):237-238. 被引量:17
  • 3刘复生.多原发癌瘤172例临床病理分析[J].中华肿瘤杂志,1979,2:113-118. 被引量:58
  • 4Molmenti EP, Molmenti H, Weinstein J, et al. Syndromie incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer[J]. Dig Dis Sci, 2003,48(1) : 187-189. 被引量:1
  • 5De Groot ME, Dukel L, Chadha-Ajwani S, et al. Massive solitary metastasis of hepatocellular carcinoma in the ovary two years after liver transplantation[J]. Eur J Obstet Gynecol Reprod Biol, 2000,90(1) : 109-111. 被引量:1
  • 6Stippel DL, Kasper HU, Schleimer K, et al. Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation[J]. Transplant Proc ,2005,37(5) :2185-2157. 被引量:1
  • 7Buell JF, Woodle ES. Syndromic incidence of ovarian cancer after liver transplantation: is breastcancer an antecedent risk? [J]. Liver Transpl,2004,10(1): 156-157. 被引量:1
  • 8Jain A, Yee L, Nalesnik MA, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result date. Transplantation, 1998,66:1193-1200. 被引量:1
  • 9Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg, 1996,2 (1) : 52-59. 被引量:1
  • 10Yao FY, Gautam M, Palese C, et al. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant, 2006,20 (5) : 617-623. 被引量:1

共引文献25

同被引文献23

  • 1袁伟升,刘鹏,王志远,刁同进,宫林.肝癌肝移植术后合并胃癌一例[J].中华胃肠外科杂志,2006,9(5):428-428. 被引量:7
  • 2朱志军,李林,张雅敏,郑虹,蒋文涛,张建军,高伟,淮明生,沈中阳.肝移植术后新发恶性肿瘤的诊治[J].中华肿瘤杂志,2007,29(3):237-238. 被引量:17
  • 3Yildirim Y, Ozyilkan O, Emiroglu R, et al. Early diagnosis of cancer in renal transplant patients: a single center experience [J]. Asian Pac J Cancer Prey, 2006, 7 (2) : 336-339. 被引量:1
  • 4Suthanthiran M, Hojo M, Maluccio M, et al. Post-trans- plantation malignancy: a cell autonomous mechanism with implications for therapy [J]. Trans Am Clin Climatol Assoc, 2009, 120: 369-388. 被引量:1
  • 5Herman M, Weinstein T, Korzets A, et al. Effect of cyclosporin A on DNA repair and cancer incidence in kid-ney transplant recipients [J]. J Lab Clin Med, 2001, 137 (1): 14-20. 被引量:1
  • 6Shihab FS, Bennett WM, Isaac J, et al. Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity [J]. Kidney Int, 2003, 63 (2): 522-533. 被引量:1
  • 7Geetha D, Tong BC, Racusen L, et al. Bladder carcino- ma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent [ J]. Transplantation, 2002, 73 (12) : 1933-1936. 被引量:1
  • 8Carpinito GA, Stadler WM, Briggman JV, et al. Urinary nuclear matrix protein as a marker for transitional cell car- cinoma of the urinary tract [J]. J Urol, 1996, 156 (4) : 1280-1285. 被引量:1
  • 9Kibar Y, Goktas S, Kilic S, et al. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer Ⅱ ( UBC Ⅱ ) test in early recur- rent transitional cell carcinoma of the bladder [J]. Ann Clin Lab Sci, 2006, 36 (1): 31-38. 被引量:1
  • 10Penn I. Development of cancer as a complication of clini- cal transplantation [J]. Transplant Proe, 1977, 9 (1): 1121-1127. 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部